Published in Can J Gastroenterol on January 01, 2002
A randomized survey of the preference of gastroenterologists for a Cochrane review versus a traditional narrative review. Can J Gastroenterol (2002) 1.49
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology (1987) 3.35
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med (1995) 2.95
Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology (1991) 2.93
Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology (1993) 2.75
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut (2000) 2.67
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med (1994) 2.52
Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology (1993) 2.46
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med (1998) 1.77
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology (1992) 1.67
Alternative medicine and general practitioners. Opinions and behaviour. Can Fam Physician (1995) 1.67
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleeding. Am J Gastroenterol (2000) 1.49
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology (1998) 1.48
Use of alternative medicine by patients attending a gastroenterology clinic. CMAJ (1990) 1.46
Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev (2000) 1.32
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology (1996) 1.31
Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology (1996) 1.29
Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest (1998) 1.27
Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. Gastroenterology (1987) 1.20
Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology (1995) 1.16
Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol (2001) 1.13
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease. Ital J Gastroenterol Hepatol (1998) 1.09
Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol (1990) 1.04
Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut (1995) 1.04
General practitioners' assessment of and interest in alternative medicine in Canada. Soc Sci Med (1995) 1.04
Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there? Gastroenterology (2000) 1.02
Gastrointestinal symptoms in ambulatory HIV-infected patients. Dig Dis Sci (1993) 1.01
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology (1996) 0.98
The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol (1998) 0.96
Erratic zidovudine bioavailability in HIV seropositive patients. J Antimicrob Chemother (1993) 0.95
Pulmonary function abnormalities in patients with ulcerative colitis. Am J Gastroenterol (1997) 0.94
Review article: treatment of Clostridium difficile infection. Aliment Pharmacol Ther (1997) 0.93
The pancreas in the degu. Exp Mol Pathol (1984) 0.92
Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol (1999) 0.92
The chronological sequence in the pathology of Crohn's disease. J Clin Gastroenterol (1988) 0.91
Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist. Can J Gastroenterol (2001) 0.91
Intestinal permeability in patients with Crohn's disease. Gut (1994) 0.90
Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock (1994) 0.89
Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis (1999) 0.89
Volume and acidity of residual gastric fluid after oral fluid ingestion before elective ambulatory surgery. CMAJ (1989) 0.89
HIV-associated non-Hodgkin's lymphoma of the gastrointestinal tract. Am J Gastroenterol (1996) 0.86
Survey of current practices among members of CAG in the follow-up of patients diagnosed with gastric ulcer. Can J Gastroenterol (1999) 0.86
Determinants of abstract acceptance for the Digestive Diseases Week--a cross sectional study. BMC Med Res Methodol (2001) 0.86
Gastrointestinal tissue cultures for HIV in HIV-infected/AIDS patients. The University of Calgary Gastrointestinal/HIV Study Group. AIDS (1992) 0.85
Reticuloendothelial system Fc receptor-mediated clearance of IgG-tagged erythrocytes from the circulation of patients with idiopathic ulcerative colitis and chronic liver disease. Hepatology (1986) 0.85
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm Bowel Dis (2000) 0.85
Zidovudine absorption and small intestinal function in HIV seropositive patients. J Antimicrob Chemother (1996) 0.83
Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther (1993) 0.82
Nutritional status and food intake in human immunodeficiency virus infection. GI/HIV Study Group. J Acquir Immune Defic Syndr (1992) 0.82
Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta. Dig Dis Sci (1991) 0.82
Peptides in the gastrointestinal tract in human immunodeficiency virus infection. The GI/HIV Study Group of the University of Calgary. Gastroenterology (1992) 0.81
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology (1988) 0.81
5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis. Am J Gastroenterol (1997) 0.80
Helping patients with Crohn's disease quit smoking. Am J Gastroenterol (2000) 0.78
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. Aliment Pharmacol Ther (2005) 0.78
Ro 15-1788 and hepatic failure. Ann Intern Med (1988) 0.78
Meglumine iodipamide (Cholografin) hepatotoxicity. Ann Intern Med (1977) 0.78
5-Aminosalicylates for prevention of recurrence in patients with Crohn's disease: time for a reappraisal? J Clin Gastroenterol (1991) 0.77
Outpatient health care utilization of patients with inflammatory bowel disease. Dig Dis Sci (1990) 0.77
Genetic markers and inflammatory bowel disease: immunoglobulin allotypes (GM, KM) and protease inhibitor. Am J Gastroenterol (1989) 0.77
Medical management of inflammatory bowel disease: old and new perspectives. Curr Opin Gastroenterol (2001) 0.77
Absence of an association between enteric parasites in the manifestations and pathogenesis of HIV enteropathy in gay men. The GI/HIV Study Group. Scand J Infect Dis (1992) 0.77
Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea. Dig Dis Sci (1991) 0.77
Perioperative blood transfusion does not prevent recurrence in Crohn's disease. A pooled analysis. J Clin Gastroenterol (1995) 0.76
Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease. Ann N Y Acad Sci (1999) 0.76
Attitudes toward smoking and smoking behaviors of patients with Crohn's disease. Am J Gastroenterol (2001) 0.76
The lipase/amylase ratio: sensitive but not specific. Gastroenterology (1992) 0.75
Issues raised by psyllium meta-analysis. Am J Clin Nutr (2001) 0.75
Medical dissolution of gallstones: an illusion? Can Med Assoc J (1983) 0.75
Gastro-esophageal reflux and asthma. Thorax (2001) 0.75
HIV-related non-Hodgkin's lymphoma in Calgary. Can J Infect Dis (1996) 0.75
Mesalazine as a maintenance treatment in Crohn's disease. Gut (1998) 0.75
Unrestricted oral fluid until three hours preoperatively: effect on gastric fluid volume and pH. Can J Anaesth (1990) 0.75
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*. Inflamm Bowel Dis (1995) 0.75
Gastric fluid volume and pH in elective surgical patients: triple prophylaxis is not superior to ranitidine alone. Can J Anaesth (1990) 0.75
Biochemical models as early predictors of the etiology of acute pancreatitis. Dig Dis Sci (1993) 0.75
A registry of clinical trials. Inflamm Bowel Dis (1996) 0.75
Aminosalicylates in the treatment of inflammatory bowel disease. Inflamm Bowel Dis (1998) 0.75
The Sunnybrook Gallstone Study: a double-blind controlled trial of chenodeoxycholic acid for gallstone dissolution. Hepatology (1985) 0.75
The Cochrane Collaboration IBD Review Group. Inflamm Bowel Dis (1996) 0.75
Enemas for IBD maintenance therapy. Dig Dis Sci (1989) 0.75
Massive cerebral edema associated with fulminant hepatic failure in acetaminophen overdose: possible role of cranial decompression. Am J Gastroenterol (1981) 0.75